nutch_noindex
CANCELAR
COVID-2019 Alert

Information about the 2019 Novel Coronavirus. Read the latest >

Información sobre el coronavirus 2019 (COVID-19). Aprenda más >

/nutch_noindex

May Chien, MD

  • Clinical Assistant Professor
Añadir a contactos (información)
  • May Chien

Ubicaciones y Horarios

Pediatric Hematology/Oncology

725 Welch Road
Palo Alto, CA 94304
Teléfono: (650) 497-8953
Facsímil: (650) 497-8959
Mapa de Direcciones y Estacionamiento

Stanford Cancer Center

875 Blake Wilbur Dr
Clinic A MC 6560
Stanford, CA  94305
Mapa de Direcciones y Estacionamiento

Especialidades médicas y/o especialidades quirúrgicas

Hematology-Oncology

Trabajo y educación

Educación

University of Southern California Keck School of Medicine, Los Angeles, CA, 05/14/2010

Últimos años de residencia

LAC+USC Internal Medicine and Pediatric Residency, Los Angeles, CA, 06/30/2014

Subespecialidad

Stanford University Hematology and Oncology Fellowship, Palo Alto, CA, 06/30/2020

Stanford University Pediatric Hematology Oncology Fellowship, Palo Alto, CA, 06/30/2020

Certificado(s) de especialidad

Hematology, American Board of Internal Medicine

Internal Medicine, American Board of Internal Medicine

Pediatrics, American Board of Pediatrics

Servicios

Hematología

Todo Publicaciones

A Blueprint for Identifying Phenotypes and Drug Targets in Complex Disorders with Empirical Dynamics. Patterns (New York, N.Y.) Krieger, M. S., Moreau, J. M., Zhang, H., Chien, M., Zehnder, J. L., Craig, M. 2020; 1 (9): 100138

Abstract

A central challenge in medicine is translating from observational understanding to mechanistic understanding, where some observations are recognized as causes for the others. This can lead not only to new treatments and understanding, but also to recognition of novel phenotypes. Here, we apply a collection of mathematical techniques (empirical dynamics), which infer mechanistic networks in a model-free manner from longitudinal data, to hematopoiesis. Our study consists of three subjects with markers for cyclic thrombocytopenia, in which multiple cells and proteins undergo abnormal oscillations. One subject has atypical markers and may represent a rare phenotype. Our analyses support this contention, and also lend new evidence to a theory for the cause of this disorder. Simulations of an intervention yield encouraging results, even when applied to patient data outside our three subjects. These successes suggest that this blueprint has broader applicability in understanding and treating complex disorders.

View details for DOI 10.1016/j.patter.2020.100138

View details for PubMedID 33336196

Impact of in utero transfusions in fetuses with hydrops fetalis due to alpha thalassemia Lianoglou, B. R., Gonzalez, V., Velez, J., Norton, M. E., Chen, B., Finley, B., Hirata, G., Ogasawara, K., MacKenzie, T. C., Brown, R. N., Sanchez-Embrey, E., Shaw, S. W., Foe, M., Bitanga, M., Chien, M., Stumbaugh, T., Thompson, A. A., Viprakasit, V., Volanakis, E. J., Vichinsky, E. MOSBY-ELSEVIER. 2020: S300S301

View details for DOI 10.1016/j.ajog.2019.11.474

View details for Web of Science ID 000504997300457

ANTICOAGULATION FOR TREATMENT OF PAIN IN VENOUS MALFORMATIONS Chien, M., Kreimer, S., Teng, J., Marqueling, A., Jeng, M. WILEY. 2018

View details for Web of Science ID 000428851200243

CLINICAL OUTCOME OF HB KHARTOUM/beta THALASSEMIA COMPOUND HETEROZYGOSITY: A GLIMPSE INTO HOMOZYGOUS HB KHARTOUM Chien, M., Glader, B. WILEY. 2018

View details for Web of Science ID 000428851200076